BioTech Drug Development Patient Experience Telemedicine 
Society for Participatory Medicine
JANUARY 27, 2022
Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. However, we are still missing the mark with patient involvement to make durable healthcare change towards a culture of patient centricity.
Digital Health Global
NOVEMBER 30, 2023
Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drug development. In a recent review paper appeared on Nature , Mittermaier et al. in 2010 to 11.4%
Expert insights. Personalized for you.
107 
Let's personalize your content